209 related articles for article (PubMed ID: 37143158)
1. Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design.
Huele EH; van der Velden JM; Kasperts N; Eppinga WSC; Grutters JPC; Suelmann BBM; Weening AA; Delawi D; Teunissen SCCM; Verkooijen HM; Verlaan JJ; Gal R
Trials; 2023 May; 24(1):307. PubMed ID: 37143158
[TBL] [Abstract][Full Text] [Related]
2. Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.
van der Velden JM; Verkooijen HM; Seravalli E; Hes J; Gerlich AS; Kasperts N; Eppinga WS; Verlaan JJ; van Vulpen M
BMC Cancer; 2016 Nov; 16(1):909. PubMed ID: 27871280
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
Rothrock RJ; Ozair A; Avendano MC; Herrera S; Appel H; Ramos S; Starosciak AK; Leon-Ariza DS; Rubens M; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha RR
Trials; 2024 Jan; 25(1):41. PubMed ID: 38217032
[TBL] [Abstract][Full Text] [Related]
5. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
6. Postoperative quality-of-life assessment in patients with spine metastases treated with long-segment pedicle-screw fixation.
Bernard F; Lemée JM; Lucas O; Menei P
J Neurosurg Spine; 2017 Jun; 26(6):725-735. PubMed ID: 28338450
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.
Doppenberg D; Besselink MG; van Eijck CHJ; Intven MPW; Koerkamp BG; Kazemier G; van Laarhoven HWM; Meijerink M; Molenaar IQ; Nuyttens JJME; van Os R; van Santvoort HC; van Tienhoven G; Verkooijen HM; Versteijne E; Wilmink JW; Lagerwaard FJ; Bruynzeel AME;
BMC Cancer; 2022 Dec; 22(1):1363. PubMed ID: 36581914
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiotherapy Followed by Surgical Stabilization Within 24 h for Unstable Spinal Metastases; A Stage I/IIa Study According to the IDEAL Framework.
Versteeg AL; van der Velden JM; Hes J; Eppinga W; Kasperts N; Verkooijen HM; Oner FC; Seravalli E; Verlaan JJ
Front Oncol; 2018; 8():626. PubMed ID: 30619760
[No Abstract] [Full Text] [Related]
9. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
[TBL] [Abstract][Full Text] [Related]
10. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for osseous low alpha-beta resistant metastases for pain relief-SOLAR-P.
Nguyen EK; Quan K; Parpia S; Tran S; Swaminath A
Radiat Oncol; 2021 Sep; 16(1):170. PubMed ID: 34479581
[TBL] [Abstract][Full Text] [Related]
12. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial.
Braam P; Lambin P; Bussink J
Trials; 2016 Feb; 17():61. PubMed ID: 26829933
[TBL] [Abstract][Full Text] [Related]
15. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
[TBL] [Abstract][Full Text] [Related]
16. High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial.
Rief H; Katayama S; Bruckner T; Rieken S; Bostel T; Förster R; Schlampp I; Wolf R; Debus J; Sterzing F
Trials; 2015 Jun; 16():264. PubMed ID: 26054533
[TBL] [Abstract][Full Text] [Related]
17. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
18. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
[TBL] [Abstract][Full Text] [Related]
19. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life Following Stereotactic Body Radiotherapy
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; El Shafie RA; Nicolay NH; Debus J; Rief H
Anticancer Res; 2018 Aug; 38(8):4961-4968. PubMed ID: 30061276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
